Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Acidosis and Tumor Progression

Secondary Lung Cancer

Cancer Diagnosis

Myc Mutations and Cancer

Cancer Pain

Cancer Research

Metastatic Migration in Cancer may be Influenced by Metabolism

What is Cancer of Unknown Primary?

Why are Cancer Cell Lines Useful?

What Role do Biobanks Play in Cancer Research?

Cancer Pathophysiology

See more featured articles »

Cancer Prevention: Lowering your Risk

What Causes Cancer?

Cancer Epidemiology

Caring for a Loved One with Cancer

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Overview of Cell Viability and Cytotoxicity

Extracellular Vesicles as Floating Cancer Biomarkers

The Cancer Cell Surface Proteome as a Therapeutic Target

What is the Tumor Microenvironment?

Transforming Cancer Care through Genomic Testing

What is Cancer?

Using Biomarkers to Detect Cancer

Assay for Monitoring and Treating Malignant Brain Tumors

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Cancer Symptoms

The Biochemistry of Breast Cancer Screening

CDK9 and Cancer

What is Tumorigenesis?

Cancer History

Exploiting Enzymes in Cancer Diagnosis and Therapy

What is Merkel Cell Carcinoma?

Cancer Classification

Microfluidic cancer treatment screen combined with flow cytometry

Living with Cancer Pain

Investigating the Molecular Mechanisms of Cancer

Hot vs Cold: the differences between tumor types

Pediatric Cancer

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Secondary Brain Cancer

Hypoxia Markers and Their Importance

Insight into Cancer Vaccines

Is Cancer a Metabolic Disorder?

Effects of Social and Economic Deprivation on Cancer Mortality

Targeted Cancer Therapies

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Cancer Pain Management

British Pioneers in Cancer Biology

Cutaneous Manifestations of Internal Malignancy

Cancer Glossary

Cancer Management

What is Immunochemotherapy?

Insights into Oncofertility

TARDIS: The Improved Method of Detecting Breast Cancer

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cancer Screening Considerations: Balancing the Benefits and Risks

Cancer Prognosis

The Effects of Cancer on Family Life

Latest Cancer News and Research

Personalized mRNA cancer vaccine cuts melanoma recurrence risk when added to immunotherapy

Adding a personalized mRNA-based cancer vaccine to immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%, according to results from the phase 3 INTerpath-001 trial presented at the ESMO Congress 2026.

24 Oct 2026

Abiraterone triplet therapy improves long-term survival in metastatic prostate cancer

Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread at diagnosis, reinforcing the value of early treatment intensification.

24 Oct 2026

Drug combination delivers promising survival gains in advanced endometrial cancer

An immunotherapy-based regimen combining durvalumab and the PARP inhibitor, olaparib, demonstrated encouraging long-term survival outcomes for patients with advanced or recurrent endometrial cancer, according to new trial results presented by researchers from The University of Texas MD Anderson Cancer Center.

24 Oct 2026

PFAS levels in United States drinking water may be underestimated

Common ways of reporting perfluoroalkyl and polyfluoroalkyl substances (PFAS)-the man-made, so-called forever chemicals that pose environmental and health threats-could underestimate the concentration of PFAS in United States drinking water by as much as half, finds a study publishing October 23 in the Cell Press journal Cell Reports Sustainability.

24 Oct 2026

Doctors explain why breast cancer screening should start at age 40

Advances in breast cancer screening and treatment are helping doctors detect the disease earlier, tailor therapies to individual patients and, in some cases, spare women from unnecessary chemotherapy, radiation and surgery.

24 Oct 2026

Nearly one third of patients with advanced melanoma saw tumors disappear completely after receiving TIL therapy plus pembrolizumab immunotherapy

Results from a clinical trial have revealed nearly one third (29.2 percent) of patients with advanced melanoma saw their tumors disappear completely on scans after receiving lifileucel TIL therapy alongside an immune checkpoint inhibitor, pembrolizumab, as a first-line treatment.

24 Oct 2026

Six-gene score could improve survival predictions for acute myeloid leukemia

The activity of six different genes can help determine patient survival of acute myeloid leukemia (AML), according to a study published today in Science Advances.

23 Oct 2026

Study reveals how cancer cells survive chemotherapy in a zombie-like state

Scientists at Trinity College Dublin have made an important breakthrough in understanding how cancer cells can evade the cell-killing effects of chemotherapy and enter a "zombie-like state", called premature senescence, that can attract the wound healing properties of the immune system.

23 Oct 2026

Common kidney tests underestimate chronic kidney disease in cancer patients

New research indicates that commonly used measures of kidney function largely underestimate the prevalence of chronic kidney disease (CKD) in patients with cancer. The findings will be presented at ASN Kidney Week 2026 October 22–25.

23 Oct 2026

KRAS-targeting vaccine prompts immune responses in pancreatic cancer patients

An investigational vaccine helped the immune system recognize and respond to mutations that drive most pancreatic cancers, according to results from a randomized phase 2 clinical trial led by Mayo Clinic researchers.

23 Oct 2026

Digital tools and phone coaching boost cancer genetic testing uptake

About 10% of cancers are linked to an inherited genetic variant, but as few as 1 in 15 cancer patients eligible for genetic testing complete it.

23 Oct 2026

Targeted drug extends survival across diverse pancreatic cancer patient groups

A new analysis of a phase 3 clinical trial found that the targeted drug daraxonrasib improved survival compared with standard chemotherapy across multiple groups of patients with advanced pancreatic cancer, including those with different RAS mutations and those without an identified RAS mutation.

23 Oct 2026